Mid-cap Health Care company DaVita has logged a 1.8% change today on a trading volume of 142,026. The average volume for the stock is 622,948.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. Based in Denver, United States the company has 70,000 full time employees and a market cap of $8,986,658,816.
The company is now trading -13.66% away from its average analyst target price of $114.0 per share. The 7 analysts following the stock have set target prices ranging from $100.0 to $142.0, and on average give DaVita a rating of hold.
Over the last 52 weeks, DVA stock has risen 9.0%, which amounts to a -5.0% difference compared to the S&P 500. The stock's 52 week high is $116.97 whereas its 52 week low is $65.28 per share. With its net margins declining an average -3.6% over the last 6 years, DaVita may not have a strong enough profitability trend to support its stock price.
Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2023-02-22 | 11,609,894 | 560,400 | 5 | -37.5 |
2022-02-11 | 11,618,797 | 978,450 | 8 | 14.29 |
2021-02-12 | 11,550,604 | 773,642 | 7 | 0.0 |
2020-02-21 | 11,388,479 | 810,981 | 7 | 600.0 |
2019-02-22 | 11,404,851 | 159,394 | 1 | -83.33 |
2018-02-23 | 10,876,634 | 663,618 | 6 |